![Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity | Journal for ImmunoTherapy of Cancer | Full Text Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity | Journal for ImmunoTherapy of Cancer | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs40425-019-0545-9/MediaObjects/40425_2019_545_Fig5_HTML.png)
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity | Journal for ImmunoTherapy of Cancer | Full Text
![Cells | Free Full-Text | New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy Cells | Free Full-Text | New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy](https://pub.mdpi-res.com/cells/cells-11-00708/article_deploy/html/images/cells-11-00708-g001.png?1645095696)
Cells | Free Full-Text | New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy
![CD39 identifies a microenvironment-specific anti-inflammatory CD8+ T-cell population in atherosclerotic lesions - ScienceDirect CD39 identifies a microenvironment-specific anti-inflammatory CD8+ T-cell population in atherosclerotic lesions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0021915019303831-fx1.jpg)
CD39 identifies a microenvironment-specific anti-inflammatory CD8+ T-cell population in atherosclerotic lesions - ScienceDirect
![Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity | Nature Immunology Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity | Nature Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41590-022-01379-9/MediaObjects/41590_2022_1379_Fig1_HTML.png)
Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity | Nature Immunology
![Frontiers | The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy Frontiers | The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy](https://www.frontiersin.org/files/Articles/1110325/fimmu-14-1110325-HTML/image_m/fimmu-14-1110325-g003.jpg)
Frontiers | The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy
![The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation - ScienceDirect The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0896841114001863-fx1.jpg)
The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation - ScienceDirect
![CD39+ tissue-resident memory CD8+ T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer | Science Immunology CD39+ tissue-resident memory CD8+ T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abn8390/asset/703491d2-9668-4b92-82a5-9f2476bc83bc/assets/images/large/sciimmunol.abn8390-f3.jpg)
CD39+ tissue-resident memory CD8+ T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer | Science Immunology
![JCI Insight - PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells JCI Insight - PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells](https://df6sxcketz7bb.cloudfront.net/manuscripts/142000/142513/medium/jci.insight.142513.ga.jpg)
JCI Insight - PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells
![The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity: Molecular Therapy The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity: Molecular Therapy](https://www.cell.com/cms/attachment/29a4499b-3123-4ddb-8e60-bcad1b15dd1f/fx1_lrg.jpg)
The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity: Molecular Therapy
![The CD39/CD73 pathway modulates regulatory T cell ( Treg ) activity.... | Download Scientific Diagram The CD39/CD73 pathway modulates regulatory T cell ( Treg ) activity.... | Download Scientific Diagram](https://www.researchgate.net/publication/267734396/figure/fig5/AS:295703533375495@1447512624838/The-CD39-CD73-pathway-modulates-regulatory-T-cell-Treg-activity-The-activation-of-T.png)
The CD39/CD73 pathway modulates regulatory T cell ( Treg ) activity.... | Download Scientific Diagram
![Preventing ATP Degradation by ASO-Mediated Knockdown of CD39 and CD73 Results in A2aR-Independent Rescue of T Cell Proliferation: Molecular Therapy - Nucleic Acids Preventing ATP Degradation by ASO-Mediated Knockdown of CD39 and CD73 Results in A2aR-Independent Rescue of T Cell Proliferation: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/asset/2df0c1cc-5370-4393-b0c0-9317a9b84aff/fx1.jpg)
Preventing ATP Degradation by ASO-Mediated Knockdown of CD39 and CD73 Results in A2aR-Independent Rescue of T Cell Proliferation: Molecular Therapy - Nucleic Acids
![CD39+ tissue-resident memory CD8+ T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer | Science Immunology CD39+ tissue-resident memory CD8+ T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abn8390/asset/aa1925cb-d7fb-452e-b2bc-9c6f4e3194c5/assets/images/large/sciimmunol.abn8390-f1.jpg)